{"id":599,"date":"2022-06-03T11:27:20","date_gmt":"2022-06-03T02:27:20","guid":{"rendered":"https:\/\/www.fgb.tamagawa-seiki.com\/english\/?post_type=technology&#038;p=599"},"modified":"2022-08-24T15:17:41","modified_gmt":"2022-08-24T06:17:41","slug":"n-iwamoto-et-al-11","status":"publish","type":"technology","link":"https:\/\/fgb.tamagawa-seiki.com\/english\/technology\/n-iwamoto-et-al-11","title":{"rendered":"N. Iwamoto et al. (2019) [nSMOL]"},"content":{"rendered":"<p><a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1347436718301393\" target=\"_blank\" rel=\"noopener noreferrer\">Regulated LC-MS\/MS bioanalysis technology for therapeutic antibodies and Fc-fusion proteins using structure-indicated approach<\/a><br \/>\nDrug Metabolism and Pharmacokinetics 34, 19 (2019)<\/p>\n","protected":false},"featured_media":0,"parent":0,"template":"","acf":[],"_links":{"self":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/technology\/599"}],"collection":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/technology"}],"about":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/types\/technology"}],"wp:attachment":[{"href":"https:\/\/fgb.tamagawa-seiki.com\/english\/wp-json\/wp\/v2\/media?parent=599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}